Barriers and facilitators to hepatitis C (HCV) screening and treatment—a description of prisoners’ perspective
Abstract Background Hepatitis C virus (HCV) infection is a global epidemic with an estimated 71 million people infected worldwide. People who inject drugs (PWID) are overrepresented in prison populations globally and have higher levels of HCV infection than the general population. Despite increased...
Main Authors: | Des Crowley, Marie Claire Van Hout, John S. Lambert, Enda Kelly, Carol Murphy, Walter Cullen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-12-01
|
Series: | Harm Reduction Journal |
Online Access: | http://link.springer.com/article/10.1186/s12954-018-0269-z |
Similar Items
-
Hepatitis C virus screening and treatment in Irish prisons from a governor and prison officer perspective - a qualitative exploration
by: D. Crowley, et al.
Published: (2018-12-01) -
Hepatitis C virus screening and treatment in Irish prisons from nurse managers’ perspectives - a qualitative exploration
by: D. Crowley, et al.
Published: (2019-06-01) -
Competing priorities and second chances - A qualitative exploration of prisoners' journeys through the Hepatitis C continuum of care.
by: Desmond Crowley, et al.
Published: (2019-01-01) -
Prison and opportunities for the management of COVID-19
by: Des Crowley, et al.
Published: (2020-06-01) -
Hepatitis C virus infection in Irish drug users and prisoners – a scoping review
by: D. Crowley, et al.
Published: (2019-08-01)